In Vivo Hip Fracture Discrimination With Quantitative Computed Tomography (QCT) (FEMFRACT)
In Vivo Discrimination of Hip Fracture With Quantitative Computed Tomography
Sponsor: Assistance Publique - Hôpitaux de Paris
Terminated
Difficulties of recruitment, lack of elligible patients
Other terminated trials from Assistance Publique - Hôpitaux de Paris
- Hepatocellular Carcinoma · Sep 2025
- Memory Consolidation · Phase NA · Aug 2025
- Knee Injuries · Apr 2025
- Metabolic Syndrome · Phase NA · Dec 2024
- Pulmonary Arterial Hypertension · Phase NA · Oct 2024
See all terminations from Assistance Publique - Hôpitaux de Paris
This observational or N/A phase trial investigates Osteoporosis and Proximal Femur Fracture and is currently terminated or withdrawn. Assistance Publique - Hôpitaux de Paris leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Apr 2018 — Jan 2021 [monthly]
Terminated
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Feb 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
For direct contact, visit the study record on ClinicalTrials.gov .